Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis.
The loss of E-cadherin gene expression can cause the dysfunction of the cell-cell junction to trigger tumor metastasis. Members of the Snail family of transcription factors are repressors of the expression of the E-cadherin gene. In this study, we showed that the activated androgen receptor (AR) is a novel repressor of E-cadherin gene expression and can promote metastasis. Our results demonstrated that the activated AR could bind to the E-cadherin promoter in vitro and in vivo. The activated AR and HDAC1 had synergistic effects in downregulating E-cadherin gene expression. Treating cells with the AR ligand, dihydrotestosterone (DHT), triggered the reduction of E-cadherin expression and induced changes in cell morphology from an epithelial-like to a mesenchymal-like appearance. When nonmetastatic breast cancer cells expressing cytoplasmic AR were transplanted into mice and the mice were treated with DHT, tumors were detected at metastatic sites, whereas no tumors were detected in transplanted mice without DHT treatment. Furthermore, clinical data from breast cancer patients with invasive ductal carcinomas showed high levels of AR expression in the nuclei and low levels of E-cadherin expression. These results suggest that, similarly to Snail and Twist, the activated AR can downregulate E-cadherin expression to promote the activation of epithelial-mesenchymal transition and tumor metastasis.
Liu
Yan-Nian
YN
Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.
Liu
Ying
Y
Lee
Han-Jung
HJ
Hsu
Yung-Hsiang
YH
Chen
Ji-Hshiung
JH
D000818:Animals; D015820:Cadherins / Q000032:analysis / Q000235:genetics*; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry; D045744:Cell Line, Tumor; D013196:Dihydrotestosterone / Q000494:pharmacology; D015536:Down-Regulation; D004847:Epithelial Cells / Q000166:cytology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology; D051379:Mice; D009362:Neoplasm Metastasis / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis; D009374:Neoplasms, Experimental / Q000473:pathology; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D011944:Receptors, Androgen / Q000032:analysis / Q000378:metabolism / Q000502:physiology*; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
C410798:AR protein, human; D015820:Cadherins; D009363:Neoplasm Proteins; D011944:Receptors, Androgen; D013196:Dihydrotestosterone
Oncogene. 1999 Jul 29;18(30):4301-12
10439038
Cell. 2006 Feb 10;124(3):615-29
16469706
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3100-5
16492776
J Biol Chem. 2004 Jul 9;279(28):29436-49
15123687
Cancer. 2003 Aug 15;98(4):703-11
12910513
Cancer Lett. 1998 Feb 13;124(1):95-103
9500197
Oncogene. 2005 Dec 15;24(56):8277-90
16116478
Endocrinology. 2006 Jan;147(1):590-8
16210365
Cancer Res. 2005 Jun 15;65(12):5445-53
15958594
Nat Rev Mol Cell Biol. 2000 Nov;1(2):91-100
11253370
Cell. 2006 Nov 17;127(4):679-95
17110329
Nat Cell Biol. 2000 Feb;2(2):84-9
10655587
Physiol Rev. 2003 Apr;83(2):337-76
12663862
Trends Genet. 1993 Sep;9(9):317-21
8236461
Mol Cell Biol. 2004 Jan;24(1):306-19
14673164
Curr Opin Cell Biol. 1993 Oct;5(5):806-11
8240824
Breast Cancer Res. 2003;5(3):164-73
12793900
Nat Rev Cancer. 2002 Jul;2(7):521-8
12094238
J Cell Biol. 1991 Apr;113(1):173-85
2007622
Nat Rev Cancer. 2003 Jun;3(6):453-8
12778135
Cancer. 1996 Apr 15;77(8 Suppl):1605-13
8608551
Proc Natl Acad Sci U S A. 1982 May;79(9):2957-61
6953441
Endocr Relat Cancer. 2003 Dec;10(4):537-60
14713266
Biochim Biophys Acta. 1994 May 27;1198(1):11-26
8199193
J Cell Sci. 2004 Aug 15;117(Pt 18):4277-87
15292402
J Biol Chem. 2001 Jul 20;276(29):27424-31
11309385
Genes Dev. 2006 Apr 1;20(7):784-94
16600910
Cancer Res. 1995 Nov 15;55(22):5195-9
7585573
J Nucl Med. 1997 Mar;38(3):402-9
9074528
Nature. 2007 Aug 2;448(7153):547-8
17671495
Cancer Res. 2008 Feb 15;68(4):1128-35
18281488
Genes Dev. 2007 Aug 15;21(16):2005-17
17699749
J Steroid Biochem Mol Biol. 2004 Nov;92(4):221-36
15663986
Trends Biochem Sci. 1999 Feb;24(2):73-6
10098402
Nat Cell Biol. 2000 Feb;2(2):76-83
10655586
FASEB J. 2002 Sep;16(11):1444-6
12205042
Nat Rev Cancer. 2002 Jun;2(6):442-54
12189386
Lancet. 1996 May 18;347(9012):1377-81
8637346
Cell. 1980 Feb;19(2):465-71
7357614
EMBO J. 1988 Dec 1;7(12):3679-84
3061804
Oncogene. 2004 Apr 15;23(17):3059-66
14981544
Int J Dev Biol. 2004;48(5-6):365-75
15349812
Nature. 2000 Jan 6;403(6765):41-5
10638745
Nucleic Acids Res. 2005 Jan 07;33(1):13-26
15640443
Cell. 2000 Jan 7;100(1):57-70
10647931
Cell. 2004 Jun 25;117(7):927-39
15210113
Biochemistry. 1979 Nov 27;18(24):5294-9
518835
Nat Rev Cancer. 2002 Aug;2(8):563-72
12154349
Eur Urol. 1998 Dec;34(6):505-11
9831793
Neoplasia. 2003 Jul-Aug;5(4):347-61
14511406
Urology. 2003 Nov;62(5 Suppl 1):3-10
14607212
J Cell Sci. 2003 Feb 1;116(Pt 3):499-511
12508111
Oncogene. 2001 Jun 28;20(29):3880-7
11439351
Nature. 2001 Mar 1;410(6824):50-6
11242036
Nat Genet. 2000 Sep;26(1):16-7
10973239